Valuation: Burning Rock Biotech Limited

Market Cap 627M 92.94M 80.45M 75.2M 68.73M 130M 8.86B 132M 882M 346M 4.43B 349M 341M 14.77B P/E 2024
-1.46x
P/E 2025 -27.1x
Enterprise Value 189M 28.07M 24.3M 22.71M 20.76M 39.11M 2.68B 39.73M 266M 104M 1.34B 105M 103M 4.46B EV / Sales 2024
0.06x
EV / Sales 2025 2x
Free-Float
61.34%
Yield 2024 *
-
Yield 2025 -
1 day+25.60%
1 week+23.08%
Current month+22.25%
1 month-3.72%
3 months-32.88%
6 months-64.90%
Current year-46.00%
1 week 8.81
Extreme 8.81
11.27
1 month 8.68
Extreme 8.68
11.27
Current year 6.79
Extreme 6.79
41.72
1 year 6.62
Extreme 6.62
41.72
3 years 2.18
Extreme 2.18
41.72
5 years 2.18
Extreme 2.18
228.3
10 years 2.18
Extreme 2.18
397.5
Manager TitleAgeSince
Corporate Officer/Principal - 2013-12-31
Chief Executive Officer 48 2013-12-31
Director of Finance/CFO - 2024-09-26
Director TitleAgeSince
Chairman 48 -
Director/Board Member 55 2014-05-31
Director/Board Member 63 2016-07-31
Change 5-day change 1-year change 3-year change Capi.($)
+23.50%+23.08%+56.77%-31.14% 92.91M
+0.10%+1.78%+33.21%+15.16% 9.82B
+2.52%+7.08% - - 1.44B
-4.67%-8.71%+6.08%-2.91% 1.43B
-0.31%-0.98%-7.12%-16.70% 1.08B
+1.86%+22.64%+73.83%+35.26% 731M
+1.25%+2.54%-21.05%-61.06% 608M
+1.14%+0.56%-13.07%-9.92% 411M
+0.12%+6.94%+97.62%+148.80% 409M
-0.47%-4.69%-6.60%+19.90% 221M
Average +2.70%+2.19%+24.41%+10.82% 1.62B
Weighted average by Cap. +0.08%+2.61%+27.48%+11.74%

Financials

2024 2025
Net sales 516M 76.45M 66.18M 61.86M 56.54M 107M 7.29B 108M 725M 285M 3.65B 287M 281M 12.15B 540M 79.97M 69.23M 64.71M 59.14M 111M 7.63B 113M 759M 298M 3.82B 300M 294M 12.71B
Net income -347M -51.37M -44.48M -41.57M -37.99M -71.6M -4.9B -72.72M -487M -191M -2.45B -193M -189M -8.16B -55.35M -8.2M -7.1M -6.64M -6.07M -11.43M -782M -11.61M -77.84M -30.54M -391M -30.8M -30.13M -1.3B
Net Debt -474M -70.2M -60.78M -56.81M -51.92M -97.84M -6.7B -99.37M -666M -261M -3.35B -264M -258M -11.16B -438M -64.87M -56.16M -52.49M -47.97M -90.4M -6.19B -91.82M -616M -242M -3.1B -244M -238M -10.31B
Logo Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
Employees
-
Date Price Change Volume
26-08-10 $10.88 +23.50% 20,068
26-08-07 $8.810 -0.79% 1,808
26-08-06 $8.880 0.00% 1,678
26-08-05 $8.880 -1.00% 1,510
26-08-04 $8.970 +1.47% 2,910